Nuvalent (NUVL) News Today → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free NUVL Stock Alerts $70.88 -1.76 (-2.42%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 4:16 AM | americanbankingnews.comNuvalent (NASDAQ:NUVL) Stock Rating Reaffirmed by WedbushMay 17 at 9:31 AM | marketbeat.comNuvalent (NASDAQ:NUVL) Earns "Outperform" Rating from WedbushWedbush reissued an "outperform" rating and issued a $99.00 price objective on shares of Nuvalent in a research report on Friday.May 17 at 4:42 AM | americanbankingnews.comMatthew Shair Sells 37,500 Shares of Nuvalent, Inc. (NASDAQ:NUVL) StockMay 16 at 4:54 PM | marketwatch.comNuvalent Gets FDA Breakthrough Therapy Designation for Lung-Cancer TreatmentMay 16 at 4:01 PM | prnewswire.comNuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655May 16 at 12:09 PM | insidertrades.comInsider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Director Sells 37,500 Shares of StockMay 15, 2024 | marketbeat.comNicholas Investment Partners LP Cuts Position in Nuvalent, Inc. (NASDAQ:NUVL)Nicholas Investment Partners LP reduced its stake in shares of Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 70.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 79,200 shares of the company's stock after selling 189,142 shares during theMay 14, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Bluebird Bio (BLUE) and Nuvalent (NUVL)May 13, 2024 | americanbankingnews.comNuvalent, Inc. (NASDAQ:NUVL) Forecasted to Earn Q1 2025 Earnings of ($0.85) Per ShareMay 12, 2024 | marketbeat.comVictory Capital Management Inc. Sells 23,853 Shares of Nuvalent, Inc. (NASDAQ:NUVL)Victory Capital Management Inc. decreased its position in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 11.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 185,121 shares of the company'sMay 11, 2024 | americanbankingnews.comNuvalent, Inc. (NASDAQ:NUVL) Given Average Recommendation of "Moderate Buy" by AnalystsMay 10, 2024 | markets.businessinsider.comNuvalent’s Promising Clinical Progress and Financial Stability Support Strong Buy RatingMay 9, 2024 | investorplace.comNUVL Stock Earnings: Nuvalent Misses EPS for Q1 2024May 9, 2024 | finanznachrichten.deNuvalent, Inc.: Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial ResultsMay 9, 2024 | markets.businessinsider.comNuvalent Q1 Loss WidensMay 9, 2024 | prnewswire.comNuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial ResultsMay 5, 2024 | insidertrades.comDeborah Ann Miller Sells 3,000 Shares of Nuvalent, Inc. (NASDAQ:NUVL) StockMay 4, 2024 | insidertrades.comInsider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Insider Sells 3,000 Shares of StockMay 2, 2024 | insidertrades.comNuvalent, Inc. (NASDAQ:NUVL) Director Matthew Shair Sells 2,000 SharesMay 1, 2024 | marketbeat.comInsider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Director Sells 2,000 Shares of StockNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) Director Matthew Shair sold 2,000 shares of the company's stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $67.51, for a total transaction of $135,020.00. Following the completion of the transaction, the director now owns 236,522 shares in the company, valued at approximately $15,967,600.22. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.April 25, 2024 | insidertrades.comNuvalent, Inc. (NASDAQ:NUVL) Director Matthew Shair Sells 37,500 SharesApril 25, 2024 | insidertrades.comNuvalent, Inc. (NASDAQ:NUVL) Director Sells $2,386,875.00 in StockApril 18, 2024 | investing.comNuvalent director Shair sells over $2.4 million in company stockApril 18, 2024 | msn.comJefferies Initiates Coverage of Nuvalent (NUVL) with Buy RecommendationApril 18, 2024 | msn.comJefferies starts Nuvalent at buy, cites lung cancer drug candidatesApril 17, 2024 | msn.comNuvalent (NUVL) Price Target Increased by 6.08% to 104.19April 17, 2024 | marketbeat.comJefferies Financial Group Initiates Coverage on Nuvalent (NASDAQ:NUVL)Jefferies Financial Group initiated coverage on Nuvalent in a report on Wednesday. They issued a "buy" rating and a $97.00 target price on the stock.April 17, 2024 | marketbeat.comNuvalent (NASDAQ:NUVL) Shares Gap Up to $64.75Nuvalent (NASDAQ:NUVL) Shares Gap Up to $64.75April 11, 2024 | insidertrades.comNuvalent, Inc. (NASDAQ:NUVL) Director Sells $2,566,500.00 in StockApril 8, 2024 | finance.yahoo.comNuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024April 8, 2024 | marketbeat.comNuvalent (NASDAQ:NUVL) Trading Down 3.2% Following Insider SellingNuvalent (NASDAQ:NUVL) Stock Price Down 3.2% on Insider SellingApril 7, 2024 | investing.comNuvalent's chief legal officer sells shares worth over $220kApril 5, 2024 | finance.yahoo.comChief Legal Officer Deborah Miller Sells 3,000 Shares of Nuvalent Inc (NUVL)April 5, 2024 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Insider Deborah Ann Miller Sells 3,000 SharesNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) insider Deborah Ann Miller sold 3,000 shares of the company's stock in a transaction on Thursday, April 4th. The stock was sold at an average price of $73.60, for a total transaction of $220,800.00. Following the transaction, the insider now owns 33,300 shares of the company's stock, valued at $2,450,880. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.April 5, 2024 | marketbeat.comVanguard Group Inc. Acquires 15,722 Shares of Nuvalent, Inc. (NASDAQ:NUVL)Vanguard Group Inc. increased its holdings in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 0.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,134,182 shares of the company's stock after buying an additional 15,7April 3, 2024 | marketbeat.comLeerink Partnrs Comments on Nuvalent, Inc.'s Q1 2024 Earnings (NASDAQ:NUVL)Nuvalent, Inc. (NASDAQ:NUVL - Free Report) - Equities research analysts at Leerink Partnrs issued their Q1 2024 EPS estimates for shares of Nuvalent in a research note issued on Monday, April 1st. Leerink Partnrs analyst A. Berens anticipates that the company will earn ($0.79) per share for the qApril 2, 2024 | marketbeat.comEquities Analysts Offer Predictions for Nuvalent, Inc.'s Q2 2024 Earnings (NASDAQ:NUVL)Nuvalent, Inc. (NASDAQ:NUVL - Free Report) - Stock analysts at Leerink Partnrs issued their Q2 2024 earnings estimates for Nuvalent in a research note issued to investors on Monday, April 1st. Leerink Partnrs analyst A. Berens forecasts that the company will post earnings of ($0.80) per share forApril 2, 2024 | marketbeat.comNuvalent (NASDAQ:NUVL) Stock Rating Upgraded by Leerink PartnrsLeerink Partnrs raised shares of Nuvalent from a "market perform" rating to an "outperform" rating in a research report on Monday.April 1, 2024 | marketbeat.comNuvalent (NASDAQ:NUVL) Upgraded at SVB LeerinkSVB Leerink upgraded shares of Nuvalent from a "market perform" rating to an "outperform" rating and increased their price objective for the stock from $69.00 to $110.00 in a research note on Monday.March 30, 2024 | insidertrades.comInsider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Insider Sells 22,000 Shares of StockMarch 29, 2024 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Insider Sells $1,654,400.00 in StockNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) insider Deborah Ann Miller sold 22,000 shares of Nuvalent stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $75.20, for a total transaction of $1,654,400.00. Following the completion of the sale, the insider now directly owns 33,300 shares of the company's stock, valued at approximately $2,504,160. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.March 28, 2024 | marketbeat.comNuvalent (NASDAQ:NUVL) Stock Price Down 2% on Insider SellingNuvalent (NASDAQ:NUVL) Shares Down 2% Following Insider SellingMarch 26, 2024 | insidertrades.comNuvalent, Inc. (NASDAQ:NUVL) Insider Darlene Noci Sells 20,000 SharesMarch 25, 2024 | finance.yahoo.comChief Development Officer Darlene Noci Sells 20,000 Shares of Nuvalent Inc (NUVL)March 25, 2024 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Insider Sells $1,550,200.00 in StockNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) insider Darlene Noci sold 20,000 shares of the business's stock in a transaction on Friday, March 22nd. The stock was sold at an average price of $77.51, for a total transaction of $1,550,200.00. Following the transaction, the insider now owns 33,300 shares of the company's stock, valued at approximately $2,581,083. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.March 22, 2024 | finance.yahoo.comCompanies Like Nuvalent (NASDAQ:NUVL) Can Afford To Invest In GrowthMarch 19, 2024 | finance.yahoo.comDirector Emily Conley Sells 13,333 Shares of Nuvalent Inc (NUVL)March 19, 2024 | marketbeat.comWellington Management Group LLP Has $71.55 Million Holdings in Nuvalent, Inc. (NASDAQ:NUVL)Wellington Management Group LLP reduced its position in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 10.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,556,367 shares of the company's stock after sellMarch 17, 2024 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Shares Acquired by Hudson Bay Capital Management LPHudson Bay Capital Management LP lifted its holdings in shares of Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 43.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 42,955 shares of the company's stock after acquiring an additional 12March 16, 2024 | finance.yahoo.comNUVL Apr 2024 100.000 call Get Nuvalent News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVL and its competitors with MarketBeat's FREE daily newsletter. Email Address [URGENT] DO NOT Touch These AI Stocks! (Ad)Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over? Click here for our #1 AI Stock for 2024 and Beyond NUVL Media Mentions By Week NUVL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUVL News Sentiment▼0.840.42▲Average Medical News Sentiment NUVL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUVL Articles This Week▼143▲NUVL Articles Average Week Get Nuvalent News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALPN News Today MDGL News Today ALKS News Today PRGO News Today CRNX News Today INSM News Today HCM News Today AXSM News Today PBH News Today APLS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NUVL) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvalent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
